Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ethanol and Scopolamine

supplement:

Ethanol

Research Papers that Mention the Interaction

The effect of hyoscine was substantially increased by the presence of alcohol and under these conditions the effect of meclozine was equally great.
British journal of industrial medicine  •  1962  |  View Paper
They also suggest that in addition to cautions regarding the use of alcohol when scopolamine is clinically prescribed due to enhanced sedative effects, enhanced stimulation may also be a concern.
We also investigated whether the dopamine D1-like receptor antagonist, SCH-23390 or the dopamine D2-like receptor antagonist, haloperidol, could block the extreme stimulant response found following co-administration of scopolamine and ethanol.
Alcoholism, clinical and experimental research  •  2009  |  View Paper
In challenge 3, when the animals received scop, both groups pretreated with 2.2 g/kg EtOH (saline + 2.2 EtOH and scop + 2.2 EtOH groups) presented higher levels of activity suggesting an interaction between EtOH and scop.
Alcoholism, clinical and experimental research  •  2007  |  View Paper
Gastrodin, isolated from the n-butanol fraction of the methanol extract, and p-hydroxybenzyl alcohol , isolated from the ethyl acetate fraction of the methanol extract, also significantly prolonged the shortened step-through latency induced by scopolamine on the passive avoidance task.
Planta medica  •  1996  |  View Paper
Conversely, in animals pretreated with scopolamine (0.25 and 0.5 mg/kg) the depressant effect of ethanol was less.
European journal of pharmacology  •  1979  |  View Paper
However, 20‐80 m g scopolamine , a non‐selective muscarinic antagonist, dosedependently decreased ethanol intake as much as 60% (p < 0.05) without altering food or water consumption.
Addiction biology  •  1997  |  View Paper